The Mental Health Crisis has been ignored for decades. Covid-19 has made this mental health catastrophe much worse -- and people are now starting to notice.
Psychedelics
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares
Cybin's new financing is priced at CAD$3.40. The Company intends to issue 8.8 million new units for total proceeds of CAD$30 million.
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
Atai Life Sciences announces the launch of a new intranasal drug delivery system, InnarisBio, based on sol-gel technology.
MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT
MindMed is preparing to commence a Phase I clinical trial on the safety/tolerance of intravenous DMT.
MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research
MINDCURE's proprietary ibogaine manufacturing has reached the second stage of development: assessing the quality of its synthetic ibogaine.
Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP
Field Trip Health to commence trading on the NASDAQ on July 27th under the symbol "FTRP".
MDMA-assisted cognitive-behavioral therapy may help couples overcome PTSD
Post-traumatic stress disorder affects roughly 7 million people in the United States alone.
Cybin Announces Overnight Marketed Public Offering of Common Shares
Cybin Inc is seeking to raise capital with an overnight offering of common shares. Pricing and size of the offering to be determined.
Substance Abuse: Global Plague, A Pot Of Gold For Psychedelic Stocks
We explain why addiction therapy likely offers the greatest long-term commercialization potential within the psychedelic drug industry.
Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta
Levitee Labs announces definitive agreements to acquire 3 specialized pharmacies, a "leading telehealth provider", and 5 addiction clinics.
Red Light Holland Announces Updated Cash Position of Approximately $30 Million
Red Light Holland reports an updated position in cash and cash equivalents of roughly CAD$30 million following its merger with Creso Pharma.
New study sheds light on how LSD’s entropic effects on the brain impact language production
Language produced under the influence of the psychedelic drug lysergic acid diethylamide displays increased levels of entropy and reduced semantic coherence, according to new research published in the journal Consciousness and Cognition.
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"
Field Trip Health has received conditional approval to list on the NASDAQ, symbol "FTRP".
The Psychedelics Revolution: Abundant Opportunities For More Public Companies
The psychedelic drug industry represents the best investment opportunity in life sciences of this century. A multitude of opportunities.
Cybin Announces Conditional Listing Approval from NYSE American
Cybin announces a conditional listing on the NYSE American exchange.